|
MEET OUR SUPPORTERS
 |
PRODUCT THEATER SUPPORTER
Thursday Lunch: 12:35 p.m. - 1:45 p.m.
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies.
|
 |
PRODUCT THEATER SUPPORTER
Saturday Lunch: 12:25 p.m. - 1:30 p.m.
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients' lives through science.
|
 |
PRODUCT THEATER SUPPORTER
Friday Lunch: 12:15 p.m. - 1:20 p.m.
Saturday Breakfast: 7:45 a.m. - 8:45 a.m.
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
|
 |
BRONZE SUPPORTER
Amgen Oncology is committed to the relentless pursuit of breakthroughs for cancer patients and their families. Our portfolio features many first-in-class oncology/hematology medicines and innovative therapies for difficult-to-treat cancers.
|
 |
BRONZE SUPPORTER
At Blueprint Medicines, we work together toward one common goal: to develop breakthrough precision medicines that allow patients to live longer, healthier lives. Our world-leading expertise in protein kinases which are proven drivers of disease, powers the relentless development of transformational medicines.
|
 |
BRONZE SUPPORTER
Pharmacyclics is an AbbVie company based in South San Francisco, California and focused on developing and commercializing small-molecule medicines for the treatment of cancers and immune-mediated diseases for which there is great unmet medical need. We seek to discover innovative therapies to improve standards of care and strive to help our patients rediscover the Magic of Normal.
|
 |
BRONZE SUPPORTER
Seagen Inc. discovers, develops, and commercializes novel medicines for cancer. For more information, visit www.seagen.com.
|
 |
WINE & CHEESE RECEPTION SPONSOR
Our commitment to helping patients and their physicians manage complex drug therapies by delivering expert individualized care and unmatched, multi-channel access has made us one of the leading specialty pharmacies in the country. We provide a full-range of pharmaceutical care, dispensing the latest FDA-approved medications.
|
 |
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next generation Antibody drug conjugate ( ADC) with highly potent and targeted pyrrolobenzodiazepine (PBD).
|
 |
Agios is a biopharmaceutical company that is fueled by connections. The Agios team is dedicated to developing therapies for genetically defined diseases, including pyruvate kinase (PK) deficiency. Agios is proud to partner with APAO to support people living with PK deficiency!
|
 |
At Apellis, we are committed to developing therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body's immune system.
|
 |
Astellas is committed to turninginnovative science into medical solutions that bring value and hope to patientsand their families. Keeping our focus on addressing unmet medical needs andconducting our business with ethics and integrity enables us to improve the healthof people throughout the Americas and around the world.
|
 |
AstraZeneca is leading a revolution in Oncology to redefine cancer care.
|
 |
Global Hematology Oncology Company
|
 |
Full-service cancer diagnostic reference laboratory.
|
 |
Daiichi Sankyo, Inc., is focused on the development of oncology and specialty medicines. Medicines approved in the U.S. include therapies for metastatic breast cancer, gastric cancer, tenosynovial giant cell tumor, IV iron therapy, thrombosis, stroke risk reduction and more.
|
 |
Pharmaceutical manufacturer
|
 |
EMK Medical Services is dedicated to offering services like sourcing, supply, import and export of medical devices, laboratory and dental products along with the objective of delivering quality services.
|
 |
Exelixis, Inc. is an oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Our discovery efforts have resulted in four commercially available products - CABOMETYX® (cabozantinib), COMETRIQ® (cabozantinib), COTELLIC® (cobimetinib) and MINNEBRO® (esaxerenone)
|
 |
Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care and research. Based in Seattle, Fred Hutch operates eight clinical care sites, providing oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states.
|
 |
Pharmaceuticals
|
 |
We create and deliver novel medicines with life-changing value. We apply cutting-edge science in antibody research and engineering to address the needs of patients. We are united by our shared values: commitment to life, teamwork, innovation, and integrity, and a drive to advance innovations that have a profound impact on patients.
|
 |
Massive Bio is an AI technology that supports physicians and patients identify clinical trials.
|
 |
Novartis is reimagining medicine to improve and extend peoples' lives. We use innovative science and digital technologies to create transformative treatments. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our medicines. About 109,000 people of more than 145 nationalities work at Novartis.
|
 |
PharmaEssentia is working to redefine the potential of proven therapies to enhance the health and quality of life for patients living with hematologic diseases. Powered by world-class expertise and grounded in pioneering science, we are developing novel treatment solutions, beginning with therapies for myeloproliferative neoplasms (MPNs).
|
 |
Rigel Pharmaceuticals is a biotechnology company dedicated to improving the lives of patients through the development and commercialization of novel small molecule drugs, focused on immune and hematologic disorders, cancer, and rare diseases.
|
 |
Sobi is dedicated to developing and delivering innovative therapies to improve the lives of rare disease patients.
|
 |
Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with cancer.
|
 |
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our history in Japan since 1781.
|
|
